CYRNQ — Cyren Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $0.00m
- -$4.80m
- $31.19m
Annual income statement for Cyren, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30.8 | 35.9 | 38.4 | 36.4 | 31.2 |
| Cost of Revenue | |||||
| Gross Profit | 18.9 | 21.4 | 22.8 | 21.6 | 15.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 44.6 | 55.2 | 56.1 | 52.1 | 53 |
| Operating Profit | -13.8 | -19.3 | -17.7 | -15.7 | -21.8 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -15.7 | -19.6 | -18.1 | -17.4 | -23.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.6 | -19.4 | -18 | -17.3 | -23 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.6 | -19.4 | -18 | -17.3 | -23 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.6 | -19.4 | -18 | -17.3 | -23 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -7.65 | -7.24 | -6.59 | -5.72 | -5.9 |